NXU Stock Overview
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for NXU from our risk checks.
Nexus AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €52.00 |
| 52 Week High | €62.00 |
| 52 Week Low | €44.30 |
| Beta | 0.85 |
| 1 Month Change | -9.41% |
| 3 Month Change | -8.93% |
| 1 Year Change | 1.76% |
| 3 Year Change | -10.50% |
| 5 Year Change | 106.35% |
| Change since IPO | 459.74% |
Recent News & Updates
Should You Investigate Nexus AG (ETR:NXU) At €52.80?
Apr 20
Nexus AG (ETR:NXU) Shares Could Be 27% Below Their Intrinsic Value Estimate
Mar 28Earnings Update: Nexus AG (ETR:NXU) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts
Mar 08Returns On Capital At Nexus (ETR:NXU) Have Stalled
Feb 10Recent updates
Should You Investigate Nexus AG (ETR:NXU) At €52.80?
Apr 20Nexus AG (ETR:NXU) Shares Could Be 27% Below Their Intrinsic Value Estimate
Mar 28Earnings Update: Nexus AG (ETR:NXU) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts
Mar 08Returns On Capital At Nexus (ETR:NXU) Have Stalled
Feb 10Why Nexus AG (ETR:NXU) Could Be Worth Watching
Jan 16Is There An Opportunity With Nexus AG's (ETR:NXU) 23% Undervaluation?
Nov 06Returns On Capital At Nexus (ETR:NXU) Have Stalled
Apr 22Is Nexus AG (ETR:NXU) Potentially Undervalued?
Apr 01Here's What To Make Of Nexus' (ETR:NXU) Decelerating Rates Of Return
Jan 06Should You Think About Buying Nexus AG (ETR:NXU) Now?
Nov 10Nexus (ETR:NXU) Is Looking To Continue Growing Its Returns On Capital
Jun 25Should You Think About Buying Nexus AG (ETR:NXU) Now?
Apr 23Nexus (ETR:NXU) Has More To Do To Multiply In Value Going Forward
Feb 23Estimating The Intrinsic Value Of Nexus AG (ETR:NXU)
Jul 30Returns On Capital At Nexus (ETR:NXU) Have Hit The Brakes
Jun 29Estimating The Intrinsic Value Of Nexus AG (ETR:NXU)
Apr 19Nexus (ETR:NXU) Hasn't Managed To Accelerate Its Returns
Mar 30Shareholders Are Thrilled That The Nexus (ETR:NXU) Share Price Increased 209%
Mar 11Do Institutions Own Nexus AG (ETR:NXU) Shares?
Feb 22Nexus AG's (ETR:NXU) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 04
Calculating The Intrinsic Value Of Nexus AG (ETR:NXU)
Jan 18We're Watching These Trends At Nexus (ETR:NXU)
Dec 29Introducing Nexus (ETR:NXU), The Stock That Zoomed 189% In The Last Five Years
Nov 30Is Nexus AG's (ETR:NXU) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jun 30Shareholder Returns
| NXU | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -4.8% | -2.5% | 0.5% |
| 1Y | 1.8% | -25.2% | 1.3% |
Return vs Industry: NXU exceeded the German Healthcare Services industry which returned -24.3% over the past year.
Return vs Market: NXU matched the German Market which returned 2.3% over the past year.
Price Volatility
| NXU volatility | |
|---|---|
| NXU Average Weekly Movement | 3.5% |
| Healthcare Services Industry Average Movement | 3.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NXU has not had significant price volatility in the past 3 months.
Volatility Over Time: NXU's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 1,930 | Ingo Behrendt | www.nexus-ag.de |
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospital information systems and integrated diagnostic modules that cover various functional requirements of hospitals, psychiatric institutions, rehabilitation facilities, and diagnostic centers, as well as nursing homes.
Nexus AG Fundamentals Summary
| NXU fundamental statistics | |
|---|---|
| Market cap | €897.76m |
| Earnings (TTM) | €24.03m |
| Revenue (TTM) | €245.24m |
37.4x
P/E Ratio3.7x
P/S RatioIs NXU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXU income statement (TTM) | |
|---|---|
| Revenue | €245.24m |
| Cost of Revenue | €175.49m |
| Gross Profit | €69.75m |
| Other Expenses | €45.72m |
| Earnings | €24.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 1.39 |
| Gross Margin | 28.44% |
| Net Profit Margin | 9.80% |
| Debt/Equity Ratio | 0% |
How did NXU perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield16%
Payout RatioDoes NXU pay a reliable dividends?
See NXU dividend history and benchmarks| Nexus dividend dates | |
|---|---|
| Ex Dividend Date | May 16 2024 |
| Dividend Pay Date | May 21 2024 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 25 days |
Does NXU pay a reliable dividends?
See NXU dividend history and benchmarks